InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Jones Aranthan II, Directeur des Affaires Corporatives. Officer active across 1 company, notably Vanda Pharmaceuticals Inc.. Cumulatively, 4 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €242k. History available since 26 July 2021. The latest transaction was filed on 15 September 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
4,277 shares@ US$12.270.012% mcap13.4% of flowCommon StockSEC:0001209191-21-056530:0
4,277 shares@ US$12.2713.4% of flowCommon StockSEC:0001209191-21-056530
7,250 shares@ US$19.693336.6% of flowCommon StockSEC:0001209191-21-048276
7,250 shares@ US$19.69330.032% mcap36.6% of flowCommon StockSEC:0001209191-21-048276:0
4 of 4 declarations
About Jones Aranthan II
Aranthan II Jones is the Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. He is responsible for managing stakeholder relations and the company's communication strategy. His expertise contributes to optimizing performance and the organization's reputation. As a member of the management team, he plays a key role in the strategic direction of the organization's activities.
